Found: 42
Select item for more details and to access through your institution.
Corrigendum to 'Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction' [Eur J Heart Fail 2022;24:782–790].
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1996, doi. 10.1002/ejhf.2676
- Publication type:
- Article
Reply to 'Sodium–glucose cotransporter 2 inhibitor treatment lowers serum uric acid in patients with heart failure with reduced ejection fraction – lessons from clinical trials'.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1994, doi. 10.1002/ejhf.2686
- By:
- Publication type:
- Article
Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1751, doi. 10.1002/ejhf.2664
- By:
- Publication type:
- Article
Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1805, doi. 10.1002/ejhf.2670
- By:
- Publication type:
- Article
Inhibiting the proximal nephron in acute heart failure - emerging data on kidney safety and efficacy.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Can subgroup analyses in randomized trials guide individualized patient care?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1802, doi. 10.1002/ejhf.2710
- By:
- Publication type:
- Article
Random admission urinary sodium for diuretic response: promise in pragmatism?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1988, doi. 10.1002/ejhf.2704
- By:
- Publication type:
- Article
Morphine in acute pulmonary oedema: a signal of harm but more questions than answers.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1963, doi. 10.1002/ejhf.2698
- By:
- Publication type:
- Article
Iron repletion in heart failure: a central chemoreceptor reflex tonic?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1950, doi. 10.1002/ejhf.2697
- By:
- Publication type:
- Article
Glucagon‐like peptide 1 receptor agonists in heart failure: the need for a rewind.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1813, doi. 10.1002/ejhf.2693
- By:
- Publication type:
- Article
Corrigendum to 'Use of evidence‐based therapy in heart failure with reduced ejection fraction across age strata' [Eur J Heart Fail 2022;24:1047–1062].
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1995, doi. 10.1002/ejhf.2691
- Publication type:
- Article
Reply to 'Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease'.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1990, doi. 10.1002/ejhf.2690
- By:
- Publication type:
- Article
Multi‐biomarker approach to predict survival and adverse cardiovascular events among patients with heart failure with preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1879, doi. 10.1002/ejhf.2689
- By:
- Publication type:
- Article
Sodium–glucose cotransporter 2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: time to deliver implementation.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1902, doi. 10.1002/ejhf.2688
- By:
- Publication type:
- Article
Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1844, doi. 10.1002/ejhf.2681
- By:
- Publication type:
- Article
Patiromer use in patients with heart failure: lessons and clinical considerations from the DIAMOND trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1744, doi. 10.1002/ejhf.2684
- By:
- Publication type:
- Article
Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR‐Preserved trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1883, doi. 10.1002/ejhf.2677
- By:
- Publication type:
- Article
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1767, doi. 10.1002/ejhf.2675
- By:
- Publication type:
- Article
Cardiopulmonary functional capacity: another piece of the puzzle of sodium–glucose cotransporter 2 inhibition in heart failure?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1827, doi. 10.1002/ejhf.2672
- By:
- Publication type:
- Article
Worsening renal function precedes and follows worsening heart failure.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1915, doi. 10.1002/ejhf.2673
- By:
- Publication type:
- Article
Sodium–glucose cotransporter 2 inhibitor treatment lowers serum uric acid in patients with heart failure with reduced ejection fraction – lessons from clinical trials. Letter regarding the article 'Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA‐HF'
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1993, doi. 10.1002/ejhf.2666
- By:
- Publication type:
- Article
Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win‐ratio analysis of the PARADISE‐MI trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1918, doi. 10.1002/ejhf.2663
- By:
- Publication type:
- Article
Reply to the letter regarding the article 'Cardiac energetics in patients with chronic heart failure and iron deficiency: an in‐vivo<sup>31</sup>P magnetic resonance spectroscopy study'.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1992, doi. 10.1002/ejhf.2625
- By:
- Publication type:
- Article
Biomarker‐driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR–Preserved trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1869, doi. 10.1002/ejhf.2607
- By:
- Publication type:
- Article
Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease. Letter regarding the article ′Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo‐controlled multicentre trial'
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1990, doi. 10.1002/ejhf.2622
- By:
- Publication type:
- Article
Assessing intrinsic renal sodium avidity in acute heart failure: implications in predicting and guiding decongestion.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1978, doi. 10.1002/ejhf.2662
- By:
- Publication type:
- Article
Albiglutide in patients with type 2 diabetes and heart failure: a post‐hoc analysis from Harmony Outcomes.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1792, doi. 10.1002/ejhf.2660
- By:
- Publication type:
- Article
Early changes in renal function after sodium–glucose cotransporter 2 inhibitor initiation in EMPEROR‐Reduced: the end of the dilemma?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1840, doi. 10.1002/ejhf.2659
- By:
- Publication type:
- Article
Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1892, doi. 10.1002/ejhf.2652
- By:
- Publication type:
- Article
Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1856, doi. 10.1002/ejhf.2649
- By:
- Publication type:
- Article
Enrolling patients in cardiogenic shock trials: are we missing someone? Insights from the Italian AltShock‐2 registry.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1748, doi. 10.1002/ejhf.2640
- By:
- Publication type:
- Article
Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON-HF trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Accelerating cardiovascular research: recent advances in translational 2D and 3D heart models.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1778, doi. 10.1002/ejhf.2631
- By:
- Publication type:
- Article
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM‐AHF trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1928, doi. 10.1002/ejhf.2630
- By:
- Publication type:
- Article
Safety and efficacy of istaroxime in patients with acute heart failure‐related pre‐cardiogenic shock – a multicentre, randomized, double‐blind, placebo‐controlled, parallel group study (SEISMiC).
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1967, doi. 10.1002/ejhf.2629
- By:
- Publication type:
- Article
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1940, doi. 10.1002/ejhf.2628
- By:
- Publication type:
- Article
Short‐term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA‐VO<sub>2</sub>): a randomized clinical trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1816, doi. 10.1002/ejhf.2560
- By:
- Publication type:
- Article
Midazolam versus morphine in acute cardiogenic pulmonary oedema: results of a multicentre, open-label, randomized controlled trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Reduced.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Letter regarding the article 'Cardiac energetics in patients with chronic heart failure and iron deficiency: an in‐vivo<sup>31</sup>P magnetic resonance spectroscopy study'.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1992, doi. 10.1002/ejhf.2574
- By:
- Publication type:
- Article
October 2022 at a glance: focus on clinical trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Issue Information.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. i, doi. 10.1002/ejhf.2425
- Publication type:
- Article